Raymond Ruff

Science TLDR

Science EN ↓ 80 episodes

Ten-minute paper summaries for scientists and experts. Two episodes a week: Mondays feature the top-scoring paper from a curated weekly digest of T cell engager, bispecific antibody, and protein engineering literature. Fridays cover the top trending paper on PubMed — any field, whatever's catching the research community's attention that week. Hosted by Raymond Ruff, a protein scientist working in translational immunotherapeutics. Audio is generated with NotebookLM; the host prompt aims for measured scientific skepticism rather than hype. Feedback and paper suggestions: sciencetldrpod@gmail.com

Author

Raymond Ruff

Category

Science

Podcast website

raymondruff.github.io

Latest episode

Jul 6, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Embodied large language models enable robots to complete complex tasks in unpredictable environments 30.03.2025

https://www.nature.com/articles/s42256-025-01005-x

Sequencing by Expansion (SBX) – a novel, high-throughput single-molecule sequencing technology 26.03.2025

https://www.biorxiv.org/content/10.1101/2025.02.19.639056v1

CD33–CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells 19.03.2025

DOI: 10.1158/2643-3230.BCD-23-0258

AlphaFold prediction of structural ensembles of disordered proteins 21.02.2025

DOI: 10.1038/s41467-025-56572-9 Key Points: - Introduces AlphaFold-Metainference, a new method combining AlphaFold predictions with physics simulations - Notable because AlphaFold was trained on structured proteins but shows surprising accuracy with disordered ones - Validated against experimental data from 11 different disordered proteins using SAXS (small-angle X-ray scattering) - Further valida...

A second-generation M1-polarized CAR macrophage with antitumor efficacy 13.02.2025

DOI: 10.1038/s41590-023-01687-8 Key Points: - Research focuses on using engineered macrophages (CAR-iMACs) instead of typical CAR T cells to fight solid tumors - Started with iPSCs (induced pluripotent stem cells) which were differentiated into macrophages and engineered with CARs - Created two versions: - First generation with CD3ζ domain - Second generation with added TIR domain - Second generat...

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis 12.02.2025

DOI: 10.1056/NEJMoa2410965 Key Points: - Phase 3 trial testing obinutuzumab (anti-CD20 monoclonal antibody) + standard therapy vs placebo + standard therapy for lupus nephritis - Primary endpoint: Complete renal response at week 76 - Notable finding: 46.4% response with obinutuzumab vs 33.1% with placebo (13.4% improvement, p=0.02) Trial Design: - 271 adult patients with active lupus nephritis - R...

Triple knockdown of CD11a, CD49d, and PSGL1 in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in mice 10.02.2025

DOI: 10.1126/scitranslmed.adl6432 Key Points: The Research Problem: CAR-T cell therapy has been successful for blood cancers but faces challenges with solid tumors Major challenge: "On-target, off-tumor toxicity" where CAR-T cells attack healthy tissues Previous patient death case: HER2-targeted CAR-T cells attacked lung tissue due to HER2 expression on lung cells Study Focus: Target: EpCAM (epith...

Deep learning enhances the prediction of HLA class I-presented CD8+ T cell epitopes in foreign pathogens 06.02.2025

DOI: 10.1038/s42256-024-00971-y Key Topics: - New deep learning model MUNIS for predicting CD8+ T-cell epitopes - Implications for vaccine development and personalized medicine - Real-world validation using Epstein-Barr virus (EBV) Background Science: - HLAI molecules display protein fragments (epitopes) on cell surfaces - CD8+ T-cells recognize foreign epitopes to trigger immune response - Tradit...

Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives 05.02.2025

DOI: https://doi.org/10.1186/s40035-025-00465-w Key Discussion Points: 1. Overview of Current Landscape - Three FDA-approved second-generation antibodies: Aducanumab, Lecanemab, Donanemab - Lecanemab recently received traditional FDA approval - Represents validation of amyloid cascade hypothesis 2. Individual Antibody Profiles: Aducanumab - Derived from memory B cells of both healthy and cognitive...

Scratching promotes allergic inflammation and host defense via neurogenic mast cell activation 04.02.2025

DOI: 10.1126/science.adn9390 Key points: The Itch-Scratch Paradox Scratching is an evolutionarily conserved behavior but seems counterproductive as it worsens inflammation Research found scratching serves both harmful and beneficial purposes: Can exacerbate allergic skin conditions Helps protect against bacterial infections like S. aureus Provides insight into why scratching is pleasurable despite...

Prior vaccination prevents overactivation of innate immune responses during COVID-19breakthrough infection 31.01.2025

DOI: 10.1126/scitranslmed.adq1086 Central Idea: This study examines how previous COVID-19 vaccination influences both innate and adaptive immune responses during breakthrough infections. The researchers found that vaccination helps prevent excessive activation of the immune system, particularly in innate immune cells like monocytes and natural killer (NK) cells. Key Concepts: Breakthrough vs Prima...

Accelerated enzyme engineering by machine-learning guided cell-free expression 23.01.2025

DOI: https://doi.org/10.1038/s41467-024-55399-0 Central Idea: This paper presents an ML-guided platform for accelerating enzyme engineering by combining cell-free protein synthesis, functional screening, and machine learning to rapidly optimize enzymes for multiple distinct chemical reactions. The approach is demonstrated by engineering variants of an amide synthetase (McbA) to improve synthesis o...

Discovery of a new class of cell‑penetrating peptides by novel phage display platform 17.01.2025

DOI: 10.1038/s41598-024-64405-w Central Idea: Researchers developed a novel phage display platform called NNJA (Novel peptides for intracellular delivery by hijacking two cell systems) that discovers cell-penetrating peptides capable of delivering therapeutic cargo to the cell cytoplasm while avoiding lysosomal degradation. This platform addresses a major challenge in the field of therapeutic deli...

Learning the language of antibody hypervariability 16.01.2025

DOI: 10.1073/pnas.2418918121 Central Idea: This paper introduces AbMAP (Antibody Mutagenesis-Augmented Processing), a novel transfer learning framework that adapts foundational protein language models (PLMs) specifically for antibody analysis. The key innovation is focusing on hypervariable regions (CDRs) while leveraging the broader protein knowledge from foundational models, achieving superior p...

System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans 13.01.2025

DOI: 10.1038/s41590-024-02036-z Central Idea: This study reveals how platelets and their precursor cells (megakaryocytes) influence the durability of vaccine-induced antibody responses. The researchers identified a platelet-associated signature that predicts how long antibody responses will last across multiple vaccine types and discovered a mechanism involving megakaryocytes supporting plasma cel...

Recombinant venom proteins in insect seminal fluid reduce female lifespan 12.01.2025

DOI: https://doi.org/10.1038/s41467-024-54863-1 Central Idea: Researchers developed a new genetic biocontrol technique called the "Toxic Male Technique" (TMT) where engineered male insects express venom proteins in their reproductive tract that reduce female lifespan after mating. This represents a paradigm shift from traditional genetic biocontrol methods by affecting females within the same gene...

Autonomous mobile robots for exploratory synthetic chemistry 15.11.2024

DOI : 10.1038/s41586-024-08173-7 Central Idea : This paper presents a modular autonomous chemical synthesis platform integrating mobile robots, a Chemspeed ISynth synthesizer, UPLC-MS, and benchtop NMR, enabling automated experimentation and heuristic decision-making for exploratory synthesis. This approach mimics human workflows by using orthogonal characterization data and is applicable to diver...

A mechanism for hypoxia-induced inflammatory cell death in cancer 14.11.2024

DOI: 10.1038/s41586-024-08136-y Central Idea: This paper elucidates a novel mechanism for hypoxia-induced inflammatory cell death in cancer, specifically pyroptosis, mediated by a PTP1B-RNF213-CYLD-SPATA2 pathway. This pathway presents potential therapeutic targets for resistant hypoxic tumors. Key Concepts: Hypoxia and Cancer: Hypoxia within the tumor microenvironment promotes resistance to thera...

Coordinated inheritance of extrachromosomal DNAs in cancer cells 13.11.2024

DOI : 10.1038/s41586-024-07861-8 Central Idea : This paper investigates the coordinated inheritance of extrachromosomal DNAs (ecDNAs) in cancer cells, revealing that distinct ecDNA species co-segregate during mitosis, influenced by intermolecular interactions and transcription. This coordinated inheritance impacts oncogene co-amplification, ecDNA specialization, and responses to targeted therapy....

Decomposing causality into its synergistic, unique, and redundant components 03.11.2024

DOI : 10.1098/rsta.2021.0150 Central Idea: This paper introduces SURD (Synergistic-Unique-Redundant Decomposition), a novel framework for quantifying causality by decomposing it into its synergistic, unique, and redundant components based on information theory. SURD overcomes limitations of existing causal inference methods, especially in complex systems with nonlinear dependencies, stochasticity,...

Probiotic neoantigen delivery vectors for precision cancer immunotherapy 25.10.2024

Authors: Redenti et al. DOI: 10.1038/s41586-024-08033-4 Central Idea: This study engineers a probiotic E. coli Nissle 1917 strain to deliver tumor-specific neoantigens, creating a potent in situ cancer vaccine. This engineered probiotic effectively stimulates anti-tumor immunity and controls or eliminates tumor growth in mouse models of colorectal cancer and melanoma. Key Concepts: Neoantigen-base...

Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies 22.10.2024

Authors: Kapetanovic et al. DOI: 10.1038/s41551-024-01255-x Central Idea: This study demonstrates a method to engineer allogeneic T cells that are unresponsive to their native target antigen, thereby reducing the risk of graft-versus-host disease (GvHD), while retaining their ability to be activated by bispecific antibodies (biAbs) for cancer immunotherapy. These "Allogeneic-Engineered-Decoupled"...

The hallmarks of cancer immune evasion 18.10.2024

Review: The Hallmarks of Cancer Immune Evasion DOI: 10.1016/j.ccell.2024.09.010 Claudia Galassi, Timothy A. Chan, Ilio Vitale & Lorenzo Galluzzi Central Idea: This review proposes a "Three Cs" framework (Camouflage, Coercion, and Cytoprotection) to categorize the diverse mechanisms cancer cells utilize to evade the immune system. Key Concepts: Camouflage: Hiding from immune detection. Downregu...

In vivo dendritic cell reprogramming for cancer immunotherapy 10.10.2024

DOI: 10.1126/science.adn9083 This episode delves into a novel approach to cancer immunotherapy: in vivo reprogramming of tumor cells into type 1 conventional dendritic cells (cDC1s) using the transcription factors PU.1, IRF8, and BATF3 (PIB). Key Findings: PIB overexpression reprograms tumor cells into cDC1-like cells in vivo, inducing robust, systemic antitumor immunity in mouse melanoma models....

Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor 11.07.2024

This episode explores groundbreaking research that uncovers a novel link between the mechanical properties of the tumor microenvironment and CD8+ T cell exhaustion, a major hurdle for effective cancer immunotherapy. Key Findings: Stiffer tumor regions, rich in collagen, harbor a higher proportion of exhausted CD8+ T cells. Mechanical stress, mimicked by culturing T cells on stiff matrices or using...

Listen to the Science TLDR podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.